Phase-1 trial of Ebola vaccine gets underway in Uganda
Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which no licensed vaccine or effective treatment currently exists.
Open on the live globe →Who reported it
- 2026-10-15 18:01 UTCAfricanews · africanews.com ↗
More from Uganda
- UEDCL commissions Shs240m power projects in Butebo 2 sources
- Commonwealth Secretary-General Botchwey to visit Uganda ahead of CHOGM 2026 2 sources
- UN, govt renew push for adequate housing 2 sources
- Copper Queens face Uganda in Olympic qualifier 2 sources
- Reckitt, Chil Group launch third phase of school hygiene programme targeting 650,000 pupils 2 sources
- Gen Salim Saleh rallies support for Uganda Coffee Group as KCB Bank Uganda joins value-addition drive 1 source
- Why motor insurance claims may be rejected or delayed 1 source
- EOC turns to digital media to expose inequality as it awaits new commissioners 1 source